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Parathyroid hormone stimulates [U-t4C]glucose incorporation into glycogen of cultured osteoblast-like 
calvaria cells. This effect is detectable only several hours after the addition of PTH and it is mimicked by 
dibutyryl cyclic AMP. In contrast to insulin (in pharmacological concentrations), PTH enhances glycogen 
formation only in calvaria cells, but not in fibroblasts. Insulin-like growth factor I in physiological concen- 
trations promotes glycogen-synthesis shortly after addition. 
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1. INTRODUCTION 
Calvaria cells in culture are a suitable model for 
studying the regulation of metabolism of osteo- 
blast-like cells in vitro [l-3]. Parathyroid hormone 
(PTH) increases cyclic AMP levels in bone cells. 
Less is known about the biological consequences 
thereof [4]. Some of the typical features of osteo- 
blastic cells, such as alkaline phosphatase, collagen 
synthesis, and citrate decarboxylation, are reduced 
by PTH [1] as well as by cyclic AMP analogues 
and adenylate cyclase stimulating agents. All in all, 
the PTH-mediated effects on osteoblast-like cells 
are catabolic (41. We now report that PTH en- 
hances glycogen synthesis in cultured calvaria 
cells. 
2. EXPERIMENTAL 
2.1. Cell culture 
Cells were cultured as in [3]. Briefly: calvaria 
were dissected from 30 newborn rats, cleaned from 
adherent connective tissue and placed in Erlen- 
meyer flasks containing 5 ml phosphate-buffered 
saline (PBS) and 2 mg collagenase/ml (Worth- 
ington Biochemical Corp., type II, lot no. 40 C 
190). The material digested free, during a 30 min 
incubation period in a 37°C shaking water bath, 
was removed and discarded, and the remaining 
bones were incubated in an identical enzyme solu- 
tion for another 60 min. The thereby released cells 
were collected, washed and plated at a density of 
0.3 m.i.o./dish (Falcon, 35 mm diam.). Fibroblasts 
were obtained from the same animals by incubat- 
ing the skin of the scalps in the same collagenase 
solution. Fibroblasts were plated at 0.2 m.i.o./dish. 
The culture medium was MEM containing 1 g 
glucose/l, 100 U penicillin/ml and 50 rug strep- 
tomycin/ml. Non-essential amino acids (1 ml/ 
100 ml) and glutamine (final cont. 2 mM) were 
routinely added. Growth medium contained 5% 
fetal calf serum (FCS). On culture day 1 (i.e., on 
the day after plating) the medium was removed, 
and unattached cells and debris were washed 
away, and fresh medium containing 5% FCS was 
added. The medium was changed once more on 
day 3, and on day 5 the cells (both types) became 
confluent. FCS (5%) was then replaced with 
human serum albumin (HSA, 2 g/l) for 2 further 
days of culture. All experiments were carried out 
7 days after the establishment of primary cultures, 
and the medium was always the above-mentioned 
HSA-supplemented MEM, in which the different 
test substances were dissolved. Parathyroid hor- 
mone (synthetic bovine PTH, amino acids l-34, 
spec. act. 6800 IU/mg) was obtained from Beck- 
man Instruments Inc., dibutyryl cyclic AMP from 
Serva. Insulin-like growth factor I (IGF I) and 
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whale insulin were kindly supplied by Dr Humbel 
(Zurich). On the day of the experiment, parallel 
dishes (usually 2) were used for the determination 
of the no. cells/dish. After detachment with trypsin 
EDTA, the cells were counted in a haemocytome- 
ter. (Generally, some 0.8 m.i.o./dish for both cell 
types.) 
2.2. [14C]Glucose incorporation into glycogen (sly- 
cogen-synthesis) 
For the measurement of glycogen formation 
from [14C]glucose, we used the same method as in 
[3]. D-[U-14C]Glucose (270 mCi/mmol) was from 
Amersham. The tracer was added to the cell cul- 
ture dishes at different times after exposure to test 
media as indicated. The pulse was terminated by 
decanting the radioactive medium and quickly 
rinsing the dishes 3 times with cold PBS before 
1 ml 20% KOH containing 5 mg glycogen (Fluka) 
was given to each dish and left at room tempera- 
ture for 40 min. The solution (including cell lysate 
and carrier glycogen) was then transferred to tubes 
and kept for 1 h at 60°C for further hydrolysis of 
proteins. The tubes were cooled in ice water and 
5 ml -20°C cold absolute ethanol was added. Pre- 
cipitation was followed by centrifugation and 2 
washes with 5 ml ethanol, 100 ~1 LiBr 5% and 
100 ~1 of KOH 1 N. Glycogen was dissolved in 
1 ml 0.1 N HCl and 0.5 ml was counted with 5 ml 
Instagel (Packard) in a p-counter (Beckman 
Instruments). 
3. RESULTS AND DISCUSSION 
Cultured calvaria cells exposed to parathyroid 
hormone for 4 h incorporated more [l%]glucose 
into glycogen during the following 2 h of incuba- 
tion than did cells in the absence of PTH (tig.la). 
This effect is dose-dependent. PTH exerts a re- 
producible effect already in small concentrations. 
The steepest part of the dose-response curve lies 
between 0.1-l nM PTH, and 5 nM stimulates 
maximally. With still higher concentrations of 
PTH, the dose-response curve begins to decline 
again. PTH is known to evoke a marked surge of 
cellular cyclic AMP in calvaria cells. This effect is 
caused by a rapid activation of adenylate cyclase. 
However, 4 and 6 h after the exposure to 1 nM 
PTH, an elevation of cellular cyclic AMP could no 
longer be detected (2 pmol/l@ cells). Cyclic AMP 
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Fig. I. Stimulation of glycogen synthesis from [ “C]glu- 
case in cultured rat calvaria cells by parathyroid hor- 
mone (PTH), insulin-like growth factor I (IGF I) and by 
insulin. Cells were cultured as described in the text: 4 h 
after exposure to test media, 1 @Zi D-[U-r4C]g1ucose 
was added to each dish and the cultures were incubated 
for further 2 h at 37°C. [14C]Glucose incorporation was 
determined as in section 2. Results are expressed as cpm 
incorporated into glycogen/ IO6 cells: (a) PTH, 2 expt, 
n = 10; (b) IGF I and insulin, 1 expt, n = 4. 
increases only slightly in cultured fibroblasts in re- 
sponse to PTH [3], and glycogen-synthesis (when 
assessed under corresponding conditions as in the 
calvaria cells) was not enhanced (table 1). There- 
fore, the effect of PTH on glycogen synthesis can 
be considered as target cell specific. In contrast, 
insulin stimulated glycogen synthesis in both cell 
types (table 1). The high concentration of this hor- 
mone required can be explained by our observa- 
tion [3] that pharmacological insulin concentra- 
tions mimic the effect of physiological concentra- 
tions of insulin-like growth factors I and II. We 
have reassessed this comparison with insulin and 
IGF I under the conditions employed in the pres- 
ent experiments (fig.lb). The effect of PTH can be 
simulated by djbutyryl cyclic AMP (table 2). The 
same observation was made with another cyclic 
AMP analogue, 8-bromo-cyclic AMP, and with 
epinephrine, another stimulator of bone-cell ade- 
nylate cyclase (not shown). These findings suggest 
that PTH-induced glycogen-synthesis may be me- 
diated by cyclic AMP. Time-course experiments 
(fig.2) revealed that enhancement of glycogen syn- 
thesis by PTH and BtzcAMP on one hand and by 
insulin and IGF I on the other hand was com- 
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Table 1 
Effects of PTH and insulin on glycogen synthesis from 









1028 + 17 589 + 20 
0.1 nM 1335260 625” 16 
I.0 nM 2131290 564 r 28 
1.0 ,uM 1458 +49 743 f 52 
Conditions were as in fig. 1. Results are expressed as cpm 
incorporated into glycogen/106 cells; mean 2 SEM, 
n = 12,3 expt 
pletely different. Whereas insulin and IGF action 
on glycogen synthesis is early in onset, PTH and 
BtzcAMP lead to an initial slight inhibition. Only 
at later times calvaria cells turned to a state of in- 
creased glycogen formation from [U-t4C]glucose. 
PTH-evoked and cyclic AMP-mediated stimula- 
tion of glycogen-synthesis requires time (several 
hours) to develop. The different time course ob- 
served with PTH and with IGF I as well as the 
additivity (5 nM PTH being a maximally effective 
PTH concentration, which is also more effective 
than maximally effective concentrations of IGF) of 
PTH and IGF I suggest a different mechanism of 
action. Another possibility, though less probable, 
would be involvement of distinct target cells, either 
several cell types or the same cell type at a dif- 
ferent stage. 
Obviously, glycogen synthesis depends on the 
detailed circumstances under which it is studied, 
Table 2 
Effects of PTH and of dibutyryl cyclic AMP (BtzcAMP) 
on glycogen synthesis from [ 14C]glucose in cultured rat 
calvaria cells 
Medium c Pm 
Control 1082 f 35 
PTH 0.1 nM 1374&39 
PTH 1.0 nM 1992+46 
Bt2cAMP 0.1 mM 1505+71 
Bt2cAMP 0.5 mM 1701298 
Conditions were as in fig. 1. Results are expressed as cpm 
incorporated into glycogen/106 cells; mean + SEM, 
n = 12,3 expt 
PTH <S/TM) 
PTH+lGFI 
Ieach 5/7M ) 
PTH iSnMi 
o-2 4-6 a-10 /I 
Fig.2. Effects of various stimuli on time course of 
glycogen synthesis from [t%]glucose in cultured rat cal- 
varia cells. Cells were cultured as described in the text. 
Dishes were pulsed (2 h) with 1 &i [t4C]glucose imme- 
diately (0 h), 4 h and 8 h, respectively, after exposure to 
test media. [t%]Glucose incorporation into glycogen was 
determined as in section 2 and is expressed as cpm in- 
corporated into glycogen/ 106 cells. The mean 2 SEM is 
given; n = 4, except in the samples treated with insulin 
or IGF I, where n = 3. Experiment: (a) control medi- 
um, parathyroid hormone (PTH, 5 nM), dibutyryl cyclic 
AMP (BtzcAMP, 0.5 mM) and insulin (0.5 PM); (b) con- 
trol medium, parathyroid hormone (PTH, 5 nM), in- 
sulin-like growth factor I (IGF I, 5 nM), and a combina- 
tion of both PTH and IGF I (each at 5 nM). 
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and especially on the glucose concentration of the 
cell culture medium. It was a consistent finding 
that under comparable conditions calvaria cells ex- 
hibited higher levels of glycogen formation than 
tibroblasts. The difference between calvaria cells 
and fibroblasts was even greater than shown in 
table 1 when higher glucose concentrations were 
used. Glycogen synthesis in the presence of higher 
glucose concentrations was increased far more in 
calvaria cells than in libroblasts. Our experiments 
were always carried out with identically handled 
cells using a culture medium containing 1 g glu- 
cose/l; i.e., a near-physiological glucose concentra- 
tion. 
4. CONCLUSIONS 
This is the first report on PTH regulation of 
glycogen metabolism in cultured osteoblast-like 
cells. In liver cells, PTH was shown to stimulate 
adenylate cyclase and glycogen breakdown [5]. 
The acute rise of cyclic AMP is the most exten- 
sively studied response to PTH in osteoblast-like 
cells. It appears to be followed, some hours later, 
by an increased incorporation rate of [U-t4C]glu- 
case into glycogen. This effect is target cell specific 
(table l), dose-dependent (lig.la, table l), and it is 
mimicked by dibutyryl cyclic AMP (table 2). PTH 
evokes this biological response at concentrations 
considerably below those required to produce easi- 
ly detectable changes in total cyclic AMP levels 131. 
Protein kinase in known to be activated with hor- 
mone concentrations some 2 orders of magnitude 
lower than those needed to get a significant in- 
crease in cellular cyclic AMP [6]. The time course 
of stimulation of glycogen synthesis by PTH is dis- 
tinct from that observed with IGF I. Considered 
together with the fact that the effects of these 
2 peptides are additive (fig.2b), we are prompted 
to propose different mechanisms of action for the 
2 hormones. 
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